Onconetix, Inc. — Director's Dealing 2022

May 27, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-05-04

Reporting Person: Garfield Jon (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-04	Stock Option	$6.45	A	100000	Acquired	2032-05-04	Common Stock, par value $0.00001 per share (100000)	Direct

Footnotes

F1: Stock options (the "Options") were granted to Mr. Garfield on May 4, 2022. The Options vest and become exercisable as follows: 25% of the Options will vest on September 15, 2022 and the remainder of the Options vest in equal monthly installments over the following 36 months.